1 documents found
Information × Registration Number 0119U102900, R & D request Title Phase III study aims to study the efficacy of ublituximab in treating multiple sclerosis (ULTIMATE study) Head Lytvynenko Nataliia V., Доктор медичних наук Registration Date 22-08-2019 Organization Ukrainian medical stomatological Academy popup.description1 Investigation of the efficacy of ulituximab in the treatment of multiple sclerosis popup.nrat_date 2024-12-10 Close
search.res_rk
Head: Lytvynenko Nataliia V.. Phase III study aims to study the efficacy of ublituximab in treating multiple sclerosis (ULTIMATE study). Ukrainian medical stomatological Academy. № 0119U102900
1 documents found

Updated: 2026-03-18